MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study.

Schuman-Olivier, Zev.
Borodovsky, Jacob T.
Steinkamp, Jackson.
Munir, Qays.
Butler, Kyle.
Greene, Mary Ann.
Goldblatt, Jonah.
Xie, Hai Yi.
Marsch, Lisa A.

Background: While buprenorphine/naloxone (B/N) is approved for opioid use disorder treatment, effective delivery of B/N comes with significant challenges. Most notably, many patients do not take medication daily as prescribed; this non-adherence worsens treatment outcomes, increases healthcare costs, and leads to persistent worries of diversion among providers and policymakers. The present study e... read more

Permanent URL
ID: tufts:28564
To Cite: DCA Citation Guide
Usage: Detailed Rights